fluorodopa f 18 has been researched along with Carcinoid Heart Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben Abdelghani, M; Blondet, C; El Ghannudi, S; Germain, P; Imperiale, A; Romain, B | 1 |
| de Vries, EG; Dierckx, RA; Glaudemans, AW; Noordzij, W; Slart, RH; Tio, RA; van Beek, AP; van der Horst-Schrivers, AN; van Ginkel, B; Walenkamp, AM | 1 |
2 other study(ies) available for fluorodopa f 18 and Carcinoid Heart Disease
| Article | Year |
|---|---|
Cardiac Metastases of Small-Bowel Carcinoid
Topics: Adult; Carcinoid Heart Disease; Carcinoid Tumor; Dihydroxyphenylalanine; Humans; Intestinal Neoplasms; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2019 |
Myocardial metastases on 6-[18F] fluoro-L-DOPA PET/CT: a retrospective analysis of 116 serotonin producing neuroendocrine tumour patients.
Topics: Carcinoid Heart Disease; Dihydroxyphenylalanine; Female; Heart Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Myocardium; Neuroendocrine Tumors; Positron-Emission Tomography; Retrospective Studies; Serotonin; Tomography, X-Ray Computed; Ultrasonography | 2014 |